Feature Channels: Lupus

Filters close
Released: 9-Nov-2022 3:15 PM EST
Knowledge is power. The latest research on arthritis is right at your fingertips
Newswise

Here are some of the latest articles that have been added to the Arthritis channel on Newswise.

Released: 8-Nov-2022 10:05 AM EST
Study Finds Half of Patients with Low-Grade Proteinuria Develop Treatable Lupus Nephritis within Two Years
American College of Rheumatology (ACR)

New research presented this week at ACR Convergence 2022, the American College of Rheumatology’s annual meeting, found that 50% of people with low-grade proteinuria, which is protein in your urine, progress to clinical proteinuria within two years and show treatable lupus nephritis on biopsies.

Released: 2-Nov-2022 11:30 AM EDT
American College of Rheumatology Educating Dermatologists and Nephrologists on Lupus Clinical Trials Racial Disparities
American College of Rheumatology (ACR)

The American College of Rheumatology (ACR) has released Continuing Medical Education (CME) for dermatologists and nephrologists to help them learn more about clinical trials for lupus patients in their treatment areas and the importance of getting more of African American/Black patients enrolled.

Released: 8-Sep-2022 11:10 AM EDT
How can you explain the pain? Get the latest research on pain management in the Pain channel
Newswise

The latest research and expert commentary on pain management.

Released: 22-Aug-2022 3:45 PM EDT
Find expert commentary on the monkeypox outbreak here
Newswise

The latest research and expert commentary on the monkeypox outbreak.

15-Aug-2022 11:45 PM EDT
Lupus pill shows promise in mice; clinical trial underway
American Chemical Society (ACS)

There’s no cure for lupus, an autoimmune disease that attacks organs. But today, scientists report they have begun phase 2 clinical trials with a pill containing a compound that, in mice, reverses organ damage and prevents death. They will present their results at ACS Fall 2022.

   
Released: 18-Aug-2022 5:05 AM EDT
Pathway uncovered for greatest lupus genetic risk factor, study shows
Michigan Medicine - University of Michigan

Researchers at Michigan Medicine have uncovered the enigmatic mechanism that genetically predisposes people to the worst effects of the most typical form of lupus, a study suggests. Researchers say the findings could potentially facilitate the discovery of safe, simple and effective treatments.

Released: 29-Jul-2022 2:05 PM EDT
Don't give up the fight. Read the latest news about drug and antibiotic resistance
Newswise

Here are some of the latest articles that have been added to the Drug Resistance channel on Newswise, a free source for journalists.

Released: 28-Jul-2022 3:40 PM EDT
ACR Statement on Access to Reproductive Healthcare
American College of Rheumatology (ACR)

The American College of Rheumatology (ACR) is deeply concerned about the U.S. Supreme Court’s Dobbs v. Jackson ruling because it negatively impacts the practice of rheumatology.

Released: 14-Jun-2022 3:15 PM EDT
"Yes, optimists live longer" and more research news on Aging for media
Newswise

Here are some of the latest articles that have been added to the Aging channel on Newswise, a free source for journalists.

       
2-Jun-2022 12:00 PM EDT
New HSS Study Defines Disease Characteristics for Patients with Undifferentiated Connective Tissue Disease
Hospital for Special Surgery

A new study by researchers at Hospital for Special Surgery (HSS) has further clarified the clinical manifestations of undifferentiated connective tissue disease (UCTD). The findings were published as an abstract in the meeting journal of the European Alliance of Associations for Rheumatology (EULAR) 2022 Congress.

2-Jun-2022 10:00 AM EDT
Study Underscores Importance of Multidisciplinary Medical Team for Pregnant Women with Lupus
Hospital for Special Surgery

A study that includes researchers at Hospital for Special Surgery (HSS) underscores the importance of a multidisciplinary medical team to counsel and provide care for women with systemic lupus erythematosus, the most common form of lupus, who become pregnant. Using a nationwide database, the investigators reviewed the records of more than 50,000 patients with lupus who gave birth over a 10-year period. Findings revealed a higher rate of fetal morbidity and severe maternal morbidity compared to women who did not have lupus.

Newswise: Study Finds Healthy-Appearing Lupus Skin Predisposed to Flares, Rashes
Released: 3-May-2022 5:05 AM EDT
Study Finds Healthy-Appearing Lupus Skin Predisposed to Flares, Rashes
Michigan Medicine - University of Michigan

A new study finds that the normal-appearing skin of lupus patients contains the same inflammatory signals that are detected when the skin develops a rash, sometimes at even higher levels. Researchers say immune cells undergo an inflammatory transformation that primes the skin without rashes for disease flares.

Released: 5-Apr-2022 3:55 PM EDT
The latest news on clinical trials is here on Newswise
Newswise

Here are some of the latest articles that have been added to the Clinical Trials channel on Newswise.

       
7-Nov-2021 9:00 AM EST
Research Reveals Racial and Ethnic Disparities Persist in Pregnancy Outcomes of Patients with Lupus
Hospital for Special Surgery

While investigators have known that maternal and fetal outcomes of pregnancy among women with systemic lupus erythematosus (SLE) have improved over time, it is unknown whether the improved outcomes are shared equally among different racial and ethnic groups. Lupus has been shown to disproportionately affect minorities of childbearing age. A new study that includes researchers from Hospital for Special Surgery (HSS) presented today at the American College of Rheumatology (ACR) annual meeting shows that pregnancy outcomes in women with lupus have improved in all racial and ethnic groups over the past decade, but disparities still exist.

Released: 2-Nov-2021 12:40 PM EDT
Study Finds Racial Gaps in Renal Complications Persist for Children with Lupus
American College of Rheumatology (ACR)

New research presented this week at ACR Convergence, the American College of Rheumatology’s annual meeting, found that while hospitalized children with juvenile lupus have fewer adverse kidney outcomes overall, significant racial gaps for developing these complications persist and do not seem to be narrowing (Abstract #0956).

Released: 1-Nov-2021 4:55 PM EDT
Nearly One Third of Lupus Patients in One Study Had Low Responses to COVID-19 Vaccines
American College of Rheumatology (ACR)

New research presented this week at ACR Convergence, the American College of Rheumatology’s annual meeting, shows that nearly 30% of patients with lupus in a multi-ethnic and multi-racial study had a low response to the new COVID-19 vaccines.

Released: 1-Nov-2021 3:40 PM EDT
Hydroxychloroquine, Mainstay Lupus Treatment, Not Associated With Serious Cardiac Complication
American College of Rheumatology (ACR)

New research presented this week at ACR Convergence, the American College of Rheumatology’s annual meeting, shows that hydroxychloroquine does not appear to be associated with QTc interval prolongation.



close
1.78792